Global Cancer Test Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 137 pages | ID: G4F71C88AFCEN
GlobalInfoResearch

Abstracts

Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year.

Scope of the Report:

This report studies the Cancer Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Test market by product type and applications/end industries.

According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.

During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.

The global Cancer Test market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Test.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

• Abbott
• Radient Pharmaceuticals
• BD Diagnostics
• Beckman Coulter
• BioCurex
• bioMerieux
• Cepheid
• CytoCore
• DiagnoCure
• Gen-Probe
• Genomic Health
• QIAGEN Marseille (Earlier Ipsogen)
• Myriad Genetics
• Panacea Pharmaceuticals
• Qiagen
• Siemens Heathcare Diagnostics
• Roche
• Ventana Medical Systems
• Trovagene
• Vermillion

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Laboratory Tests
• Genetic Tests
• Imaging
• Endoscopy

Market Segment by Applications, can be divided into

• Bladder Cancer Test
• Breast Cancer Test
• Cervical Cancer Test
• Colorectal (Colon) Cancer Test
• Ovarian Cancer Test
• Prostate Cancer Test
• Liver Cancer Test
• Flow Cytometry
• Other Organ Specific Cancer Test
  
  

Contents

1 CANCER TEST MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Test
1.2 Classification of Cancer Test by Types
  1.2.1 Global Cancer Test Revenue Comparison by Types (2017-2023)
  1.2.2 Global Cancer Test Revenue Market Share by Types in 2017
  1.2.3 Laboratory Tests
  1.2.4 Genetic Tests
  1.2.5 Imaging
  1.2.6 Endoscopy
1.3 Global Cancer Test Market by Application
  1.3.1 Global Cancer Test Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Bladder Cancer Test
  1.3.3 Breast Cancer Test
  1.3.4 Cervical Cancer Test
  1.3.5 Colorectal (Colon) Cancer Test
  1.3.6 Ovarian Cancer Test
  1.3.7 Prostate Cancer Test
  1.3.8 Liver Cancer Test
  1.3.9 Flow Cytometry
  1.3.10 Other Organ Specific Cancer Test
1.4 Global Cancer Test Market by Regions
  1.4.1 Global Cancer Test Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Cancer Test Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Test Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Test Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Cancer Test Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Test Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Test (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Abbott
  2.1.1 Business Overview
  2.1.2 Cancer Test Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Abbott Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.2 Radient Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Cancer Test Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Radient Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.3 BD Diagnostics
  2.3.1 Business Overview
  2.3.2 Cancer Test Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 BD Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.4 Beckman Coulter
  2.4.1 Business Overview
  2.4.2 Cancer Test Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Beckman Coulter Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioCurex
  2.5.1 Business Overview
  2.5.2 Cancer Test Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 BioCurex Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMerieux
  2.6.1 Business Overview
  2.6.2 Cancer Test Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 bioMerieux Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cepheid
  2.7.1 Business Overview
  2.7.2 Cancer Test Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Cepheid Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.8 CytoCore
  2.8.1 Business Overview
  2.8.2 Cancer Test Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 CytoCore Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.9 DiagnoCure
  2.9.1 Business Overview
  2.9.2 Cancer Test Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 DiagnoCure Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gen-Probe
  2.10.1 Business Overview
  2.10.2 Cancer Test Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Gen-Probe Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genomic Health
  2.11.1 Business Overview
  2.11.2 Cancer Test Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Genomic Health Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.12 QIAGEN Marseille (Earlier Ipsogen)
  2.12.1 Business Overview
  2.12.2 Cancer Test Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.13 Myriad Genetics
  2.13.1 Business Overview
  2.13.2 Cancer Test Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Myriad Genetics Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.14 Panacea Pharmaceuticals
  2.14.1 Business Overview
  2.14.2 Cancer Test Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Panacea Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.15 Qiagen
  2.15.1 Business Overview
  2.15.2 Cancer Test Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Qiagen Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.16 Siemens Heathcare Diagnostics
  2.16.1 Business Overview
  2.16.2 Cancer Test Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Siemens Heathcare Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.17 Roche
  2.17.1 Business Overview
  2.17.2 Cancer Test Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Roche Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.18 Ventana Medical Systems
  2.18.1 Business Overview
  2.18.2 Cancer Test Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Ventana Medical Systems Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.19 Trovagene
  2.19.1 Business Overview
  2.19.2 Cancer Test Type and Applications
    2.19.2.1 Product A
    2.19.2.2 Product B
  2.19.3 Trovagene Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.20 Vermillion
  2.20.1 Business Overview
  2.20.2 Cancer Test Type and Applications
    2.20.2.1 Product A
    2.20.2.2 Product B
  2.20.3 Vermillion Cancer Test Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CANCER TEST MARKET COMPETITION, BY PLAYERS

3.1 Global Cancer Test Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Cancer Test Players Market Share
  3.2.2 Top 10 Cancer Test Players Market Share
3.3 Market Competition Trend

4 GLOBAL CANCER TEST MARKET SIZE BY REGIONS

4.1 Global Cancer Test Revenue and Market Share by Regions
4.2 North America Cancer Test Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Test Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Test Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Test Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Test Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CANCER TEST REVENUE BY COUNTRIES

5.1 North America Cancer Test Revenue by Countries (2013-2018)
5.2 USA Cancer Test Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Test Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Test Revenue and Growth Rate (2013-2018)

6 EUROPE CANCER TEST REVENUE BY COUNTRIES

6.1 Europe Cancer Test Revenue by Countries (2013-2018)
6.2 Germany Cancer Test Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Test Revenue and Growth Rate (2013-2018)
6.4 France Cancer Test Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Test Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Test Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC CANCER TEST REVENUE BY COUNTRIES

7.1 Asia-Pacific Cancer Test Revenue by Countries (2013-2018)
7.2 China Cancer Test Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Test Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Test Revenue and Growth Rate (2013-2018)
7.5 India Cancer Test Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Test Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA CANCER TEST REVENUE BY COUNTRIES

8.1 South America Cancer Test Revenue by Countries (2013-2018)
8.2 Brazil Cancer Test Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Test Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Test Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE CANCER TEST BY COUNTRIES

9.1 Middle East and Africa Cancer Test Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Test Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Test Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Test Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Test Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Test Revenue and Growth Rate (2013-2018)

10 GLOBAL CANCER TEST MARKET SEGMENT BY TYPE

10.1 Global Cancer Test Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Test Market Forecast by Type (2018-2023)
10.3 Laboratory Tests Revenue Growth Rate (2013-2023)
10.4 Genetic Tests Revenue Growth Rate (2013-2023)
10.5 Imaging Revenue Growth Rate (2013-2023)
10.6 Endoscopy Revenue Growth Rate (2013-2023)

11 GLOBAL CANCER TEST MARKET SEGMENT BY APPLICATION

11.1 Global Cancer Test Revenue Market Share by Application (2013-2018)
11.2 Cancer Test Market Forecast by Application (2018-2023)
11.3 Bladder Cancer Test Revenue Growth (2013-2018)
11.4 Breast Cancer Test Revenue Growth (2013-2018)
11.5 Cervical Cancer Test Revenue Growth (2013-2018)
11.6 Colorectal (Colon) Cancer Test Revenue Growth (2013-2018)
11.7 Ovarian Cancer Test Revenue Growth (2013-2018)
11.8 Prostate Cancer Test Revenue Growth (2013-2018)
11.9 Liver Cancer Test Revenue Growth (2013-2018)
11.10 Flow Cytometry Revenue Growth (2013-2018)
11.11 Other Organ Specific Cancer Test Revenue Growth (2013-2018)

12 GLOBAL CANCER TEST MARKET SIZE FORECAST (2018-2023)

12.1 Global Cancer Test Market Size Forecast (2018-2023)
12.2 Global Cancer Test Market Forecast by Regions (2018-2023)
12.3 North America Cancer Test Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Test Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Test Revenue Market Forecast (2018-2023)
12.6 South America Cancer Test Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Test Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Test Picture
Table Product Specifications of Cancer Test
Table Global Cancer Test and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Test Revenue Market Sha